Quin Van
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
- Hematology 11
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 2
- Oncology 11
- Cytokine Signaling Pathways and Interactions 9
- Co-authors
- DAVID M. HARRIS (23 shared papers)Zeev Estrov (23 shared papers)Moshe Talpaz (15 shared papers)Hagop Kantarjian (13 shared papers)Stefan H Faderl (13 shared papers)Bharat Bhushan Aggarwal (3 shared papers)Shishir Shishodia (2 shared papers)Elihu H. Estey (5 shared papers)
- Journals
- Blood (10 papers)Leukemia Research (3 papers)Cancer Research (2 papers)International Journal of Cancer (2 papers)Journal of Clinical Apheresis (1 paper)
- Partner nations
- United StatesFinland
In The Last Decade
Quin Van
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 78
- Geriatrics and Gerontology 101
- Hematology 184
- Oncology 368
- Cancer Research 151
- Genetics 104
Countries citing papers authored by Quin Van
This map shows the geographic impact of Quin Van's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quin Van with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quin Van more than expected).
Fields of papers citing papers by Quin Van
This network shows the impact of papers produced by Quin Van. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quin Van. The network helps show where Quin Van may publish in the future.
Co-authors
The 25 scholars most cited alongside Quin Van, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 271 | |
| 2 | 1998 | 127 | |
| 3 | 2007 | 120 | |
| 4 | 1996 | 84 | |
| 5 | 2005 | 73 | |
| 6 | 1999 | 73 | |
| 7 | Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia. | 1999 | 68 |
| 8 | 2003 | 55 | |
| 9 | 1995 | 42 | |
| 10 | 2006 | 35 | |
| 11 | 1998 | 33 | |
| 12 | WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML). | 2005 | 26 |
| 13 | 2003 | 25 | |
| 14 | 2009 | 16 | |
| 15 | 1997 | 13 | |
| 16 | 1998 | 11 | |
| 17 | 1998 | 11 | |
| 18 | WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity. | 2002 | 9 |
| 19 | 2006 | 5 | |
| 20 | 2004 | 3 |
About Quin Van
Quin Van is a scholar working on Hematology, Oncology, Genetics, Immunology and Molecular Biology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Cytokine Signaling Pathways and Interactions (9 papers), Cell death mechanisms and regulation (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Retinoids in leukemia and cellular processes (4 papers), NF-κB Signaling Pathways (3 papers), Mast cells and histamine (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Geriatrics and Gerontology (101 citations), Hematology (184 citations), Oncology (368 citations), Cancer Research (151 citations) and Genetics (104 citations). Quin Van has collaborated with scholars based in United States and Finland. Frequent co-authors include DAVID M. HARRIS, Zeev Estrov, Moshe Talpaz, Hagop Kantarjian, Stefan H Faderl, Bharat Bhushan Aggarwal, Shishir Shishodia, Elihu H. Estey, Alessandra Ferrajoli and Steven Mitchell Kornblau. Their work appears in journals such as Blood, Leukemia Research, Cancer Research, International Journal of Cancer and Journal of Clinical Apheresis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.